More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases

Amitza
Healthcare
Lowey Dannenberg, on behalf of named plaintiff Premera Blue Cross, is leading a class on behalf of Third-Party Payers of Amitiza (Lubiprostone) against Takeda Pharmaceutical Company Ltd. and related entities. […]

Amgen
Health Care, Healthcare
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. […]

Adobe Class Action
Data Breach and Privacy, Existing Cases
On April 3, 2025, Lowey filed a data privacy class action against Adobe, Inc. alleging it used consumers’ personally identifiable information and online activity to create user profiles without obtaining user consent. The action alleges Adobe used this information to facilitate targeting advertising on behalf of its clients.
News
Lowey Wins Preliminary Approval of Ranbaxy Purchasers’ $145M Settlement
On April 28, 2022 U.S. District Court Judge Nathanial M. Gorton in the District of Massachusetts preliminarily approved one of the largest pharmaceutical antitrust settlements ever recovered on behalf of classes of end-payors. The proposed settlement provides for the…
Blog
SEC to Attorneys: Help Register Cryptocurrencies Instead of Advising on How to Skirt Securities Laws
On November 4, 2021, U.S. Securities and Exchange Commission (“SEC”) Chairman Gary Gensler spoke at the Securities Enforcement Forum. While Gensler spoke on a variety of topics related to the agency’s enforcement mission, his remarks on cryptocurrencies, particularly as they relate to attorneys,…





